Johnson & Johnson Reports 2018 Fourth-Quarter Results:
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Johnson & Johnson (JNJ) PT Lowered to $145 at Raymond James
January 23, 2019 7:38 AM ESTRaymond James analyst Jayson Bedford lowered the price target on Johnson & Johnson (NYSE: JNJ) to $145.00 (from $149.00) while maintaining a Outperform rating.
... MoreJohnson & Johnson (JNJ) PT Lowered to $144 at RBC Capital
January 23, 2019 6:53 AM ESTRBC Capital analyst Glenn Novarro lowered the price target on Johnson & Johnson (NYSE: JNJ) to $144.00 (from $155.00) while maintaining a Outperform rating.
Novarro notes management has set conservative 2019 guidance. As such, he expects the 'beat and raises' to continue.
... MoreJohnson & Johnson (JNJ) Tops Q4 EPS by 2c, Offers FY Guidance
January 22, 2019 6:41 AM ESTJohnson & Johnson (NYSE: JNJ) reported Q4 EPS of $1.97, $0.02 better than the analyst estimate of $1.95. Revenue for the quarter came in at $20.4 billion versus the consensus estimate of $20.17 billion.
GUIDANCE:
Johnson & Johnson sees FY2019 EPS of $8.50-$8.65, versus the consensus of $8.61.... More
